Literature DB >> 28116759

Improvement of a patient's circadian rhythm sleep disorders by aripiprazole was associated with stabilization of his bipolar illness.

Tetsuo Tashiro1.   

Abstract

Splitting of the behavioural activity phase has been found in nocturnal rodents with suprachiasmatic nucleus (SCN) coupling disorder. A similar phenomenon was observed in the sleep phase in the diurnal human discussed here, suggesting that there are so-called evening and morning oscillators in the SCN of humans. The present case suffered from bipolar disorder refractory to various treatments, and various circadian rhythm sleep disorders, such as delayed sleep phase, polyphasic sleep, separation of the sleep bout resembling splitting and circabidian rhythm (48 h), were found during prolonged depressive episodes with hypersomnia. Separation of sleep into evening and morning components and delayed sleep-offset (24.69-h cycle) developed when lowering and stopping the dose of aripiprazole (APZ). However, resumption of APZ improved these symptoms in 2 weeks, accompanied by improvement in the patient's depressive state. Administration of APZ may improve various circadian rhythm sleep disorders, as well as improve and prevent manic-depressive episodes, via augmentation of coupling in the SCN network.
© 2017 The Authors. Journal of Sleep Research published by John Wiley & Sons Ltd on behalf of European Sleep Research Society.

Entities:  

Keywords:  aripiprazole; biological oscillator; bipolar disorder; circadian rhythm sleep disorders; suprachiasmatic nucleus

Mesh:

Substances:

Year:  2017        PMID: 28116759     DOI: 10.1111/jsr.12496

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  5 in total

1.  Efficacy of a Combination Therapy for Difficulties Waking Up in Non-School-Attending Students.

Authors:  Noriyuki Konishi; Hajime Kumagai; Hiroyuki Sawatari; Tetsuro Hoshino; Yoko Murase; Maiko Yamaguchi; Ayako Urabe; Yuka Kiyohara; Aki Arita; Masayo Baku; Ryujiro Sasanabe; Toshiaki Shiomi
Journal:  J Clin Med       Date:  2022-06-08       Impact factor: 4.964

2.  DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer's Disease.

Authors:  Jacqueline Chyr; Haoran Gong; Xiaobo Zhou
Journal:  Biomolecules       Date:  2022-01-24

3.  Aripiprazole-induced sleep-related eating disorder: a case report.

Authors:  Nobuyuki Kobayashi; Masahiro Takano
Journal:  J Med Case Rep       Date:  2018-04-05

4.  Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation.

Authors:  Yuki Omori; Takashi Kanbayashi; Yohei Sagawa; Aya Imanishi; Ko Tsutsui; Yuya Takahashi; Masahiro Takeshima; Manabu Takaki; Seiji Nishino; Tetsuo Shimizu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-18       Impact factor: 2.570

5.  Effect of aripiprazole on non-24-hour sleep-wake rhythm disorder comorbid with major depressive disorder: a case report.

Authors:  Kentaro Matsui; Yoshikazu Takaesu; Takeshi Inoue; Ken Inada; Katsuji Nishimura
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-19       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.